The annual list, now in its 17th year, was designed to celebrate companies that make ethical business practices a high priority. 

For the first time, Medicare will have the ability to negotiate prices of certain medications. These negotiations will focus on key questions such as the drug's benefits, the extent to which it fulfills an unmet medical need and its impact on Medicare beneficiaries.

When human counselors are unavailable to provide work-based wellness coaching, robots can substitute—as long as the workers are comfortable with emerging technologies and the machines aren’t overly humanlike.

The Medicare Payment Advisory Commission (MedPAC) wants to tie physician payments to inflation. Healthcare groups say it doesn't go far enough

A significant portion of U.S. adults have some past-due medical debt, according to a recent study from the Urban Institute, and the majority of those with debt owe non-profit hospitals.

Along with expanding research into large-language models to rival OpenAI’s ChatGPC, the search-engine king is working on AI for improving maternal care, ultrasound access and tuberculosis screening.

Provention Bio's TZIELD is the first and only therapy to delay the onset of Stage 3 type 1 diabetes (T1D) in adults and pediatric patients aged 8 years and older with Stage 2 T1D. 

According to the complaint, Rite Aid allegedly filled “at least” hundreds of thousands of unlawful prescriptions for controlled substances that lacked legitimate medical purpose, were not for a medically accepted indication or were not issued in the usual course of professional practice.

A new Alzheimer’s disease drug, Leqembi (lecanemab), will be covered by the Veterans Affairs for some patients, making the VA the first insurer to cover the drug.

Wary consumers can be convinced to allow AI into their healthcare habits by communications campaigns tuned to the ancient rhetorical categories of ethos, pathos and logos.